AbbVie volunteers return to serving global communities through Week of Possibilities

With creativity and resilience, 15,000 employees go the distance to serve.

Magnified featuring Sanjay Narayan

At a crossroad in his career, our chief ethics and compliance officer chose a path in pharma over the FBI. See where the journey led him.

Unlocking the next level of protein degradation

What have we learned about degradomers? See how our team is elevating the science, from exploring gene therapy to degrading specific tissues.

Inside the biology of aging: How do scientists tackle a planet-wide diagnosis?

See how the AbbVie-Calico Life Sciences collaboration turns the traditional partnership upside down to tackle age-related diseases.

How we’re advancing our vision of equity and inclusion

Our 2022 priorities build on our commitment to valuing differences and enhancing an inclusive culture.

Magnified featuring Darin Messina

From neuroscience to ophthalmology to bioengineering, see how our head of aesthetic science follows his passions to bring new opportunities to patients.

How can we offer new hope for people with Parkinson’s disease?

The ongoing search for an answer sparked this doctor’s decades-long career in neurodegenerative disease research.

Ready, set, launch: AbbVie opens new facility in the Bay Area

In the birthplace of biotech, we’re continuing our investment in innovation. 

Can unlocking one million genomes help us discover medicines faster?

With the most complete human genome sequenced yet, AbbVie’s Genomics Research Center aims to find out.

AbbVie’s approach to learning is unique – here are 3 reasons why

Leaders have made learning a part of the culture and empower employees to take charge of their development